Xylem Inc. (NYSE:XYL) – Equities researchers at Oppenheimer Holdings upped their FY2018 earnings estimates for shares of Xylem in a research note issued to investors on Wednesday. Oppenheimer Holdings analyst J. Giannakouros now anticipates that the firm will post earnings of $2.70 per share for the year, up from their previous estimate of $2.65.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, November 1st. The company reported $0.54 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.53 by $0.01. The firm earned $897 million during the quarter, compared to analysts’ expectations of $913.53 million. Xylem had a return on equity of 16.38% and a net margin of 8.83%. Xylem’s quarterly revenue was down .6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.49 EPS.

Earnings History and Estimates for Xylem (NYSE:XYL)

Other equities research analysts also recently issued reports about the company. Northcoast Research assumed coverage on Xylem in a research note on Thursday. They issued a “buy” rating for the company. RBC Capital Markets set a $51.00 price target on Xylem and gave the stock a “buy” rating in a research note on Tuesday, August 16th. Royal Bank Of Canada raised their price target on Xylem from $47.00 to $51.00 and gave the stock an “outperform” rating in a research note on Tuesday, August 16th. Janney Montgomery Scott raised Xylem from a “neutral” rating to a “buy” rating and raised their price target for the stock from $50.00 to $52.00 in a research note on Wednesday, November 2nd. Finally, Canaccord Genuity reaffirmed a “hold” rating and set a $50.00 price target (up from $45.00) on shares of Xylem in a research note on Tuesday, August 16th. Eight research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $46.69.

Xylem (NYSE:XYL) traded down 1.11% during trading on Thursday, hitting $53.41. The stock had a trading volume of 197,871 shares. Xylem has a 52 week low of $31.67 and a 52 week high of $54.99. The firm has a market cap of $9.58 billion, a PE ratio of 29.64 and a beta of 1.18. The company’s 50-day moving average is $50.21 and its 200 day moving average is $47.83.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 7th. Shareholders of record on Wednesday, November 9th will be issued a $0.1549 dividend. This represents a $0.62 dividend on an annualized basis and a yield of 1.15%. The ex-dividend date of this dividend is Monday, November 7th. Xylem’s dividend payout ratio (DPR) is currently 34.44%.

In other news, SVP Claudia S. Toussaint sold 5,300 shares of Xylem stock in a transaction that occurred on Friday, November 4th. The stock was sold at an average price of $47.27, for a total transaction of $250,531.00. Following the sale, the senior vice president now owns 44,033 shares of the company’s stock, valued at approximately $2,081,439.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Colin R. Sabol sold 27,473 shares of Xylem stock in a transaction that occurred on Thursday, September 8th. The stock was sold at an average price of $50.91, for a total value of $1,398,650.43. Following the sale, the insider now directly owns 65,530 shares in the company, valued at approximately $3,336,132.30. The disclosure for this sale can be found here. 0.77% of the stock is owned by company insiders.

Several hedge funds have recently made changes to their positions in XYL. FMR LLC raised its stake in shares of Xylem by 74.1% in the second quarter. FMR LLC now owns 5,956,085 shares of the company’s stock valued at $265,940,000 after buying an additional 2,534,911 shares during the last quarter. Bessemer Group Inc. increased its position in Xylem by 43,570.6% in the second quarter. Bessemer Group Inc. now owns 1,593,977 shares of the company’s stock valued at $71,171,000 after buying an additional 1,590,327 shares during the period. Janus Capital Management LLC increased its position in Xylem by 225.0% in the second quarter. Janus Capital Management LLC now owns 1,215,657 shares of the company’s stock valued at $54,279,000 after buying an additional 841,565 shares during the period. Ameriprise Financial Inc. increased its position in Xylem by 39.3% in the third quarter. Ameriprise Financial Inc. now owns 2,771,725 shares of the company’s stock valued at $145,374,000 after buying an additional 782,105 shares during the period. Finally, American Century Companies Inc. increased its position in Xylem by 190.6% in the second quarter. American Century Companies Inc. now owns 1,161,281 shares of the company’s stock valued at $51,851,000 after buying an additional 761,695 shares during the period. 85.03% of the stock is currently owned by institutional investors.

Xylem Company Profile

Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

5 Day Chart for NYSE:XYL

Receive News & Stock Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related stocks with our FREE daily email newsletter.